The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection

Sci Rep. 2016 Aug 17:6:31604. doi: 10.1038/srep31604.

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) represents a complication of bisphosphonate treatment that responds poorly to standard treatment. In a retrospective cohort study we investigated a possible role of Actinomyces spp. in the pathogenesis of MRONJ. Deep biopsies of necrotic bone were collected during surgical treatment of MRONJ and evaluated by histology and microbiology for the presence of Actinomyces spp. Microbiological, demographic and clinicpathological data were analyzed for risk of Actinomyces-associated MRONJ. Between 2005 and 2014, 111 patients suffering from histologically-confirmed MRONJ were identified. Actinomyces spp. were detected in 99 cases (89%) by histology and in six further patients by microbiological culture. A diverse microbial flora was found in all specimens without association with Actinomyces spp. Demographic and clinicopathological characteristics did not separate significantly Actinomyces-positive from Actinomyces-negative cases. Our observations confirm previous reports of a high prevalence of Actinomyces spp. in MRONJ in the single largest cohort available up to now. The high prevalence of Actinomyces spp. and the lack of clinicopathological risk factors underline the prominent role of Actinomyces spp. in MRONJ and may change the current understanding of MRONJ. Established prolonged antimicrobial treatment regimens against Actinomyces spp. infection could therefore be a mainstay of future MRONJ management.

MeSH terms

  • Actinomyces / isolation & purification
  • Actinomyces / pathogenicity*
  • Aged
  • Diphosphonates / adverse effects*
  • Female
  • Humans
  • Jaw Diseases / chemically induced*
  • Jaw Diseases / microbiology
  • Male
  • Middle Aged
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / microbiology
  • Retrospective Studies
  • Risk Factors

Substances

  • Diphosphonates